NCIC CTG IND 113: two phase I dose escalation pharmacokinetic (PK) studies of BAY 12-9566 (BAY) in combination with either doxorubicin (DOX) or modulated 5-fluorouracil (FU)

✍ Scribed by Hirte, H.; Stewart, D.; Goel, R.; Chouinard, E.; Huan, S.; Elias, I.; Matthews, S.; Seymour, L.

• Book ID: 123336770
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 163 KB
• Volume: 35
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(99)81556-1